Policy changes make India a global Pharma powerhouse, says Hikal Vice Chairman and Managing Director Hiremath
“India’s ₹15,000-crore PLI scheme for bulk drugs and a broader PLI for formulations have improved the economic attractiveness of Indian manufacturing,” MD of Hikal Ltd. said
“India’s ₹15,000-crore PLI scheme for bulk drugs and a broader PLI for formulations have improved the economic attractiveness of Indian manufacturing,” MD of Hikal Ltd. said
What's Your Reaction?
